News and Media

Latest News Release
04/13/2021

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...

Top feature box IMAGE ONLY - COMPANY NEWS

Company News

Cardinal Health Announces Quarterly Dividend and Preliminary Shareholder Voting Results at Annual Meeting
11/02/2011

DUBLIN, Ohio, Nov. 2, 2011 /PRNewswire/ — Cardinal Health today announced that the board of directors approved a regular quarterly dividend of $0.215 per share, payable Jan. 15, 2012, to shareholders of record on Jan. 1, 2012.  This is the 109th consecutive regular quarterly dividend.

In addition, the preliminary results of shareholder voting at its annual meeting of shareholders were also released. Based on preliminary voting results, shareholders re-elected all 12 members to the board, ratified Ernst & Young as the company's independent registered public accounting firm and approved the company's long-term incentive plan. In addition, shareholders approved, on an advisory basis, the compensation of certain executive officers and selected, on an advisory basis, an annual vote on the frequency of future advisory votes on executive compensation. One shareholder proposal failed to pass. Final results will be posted on the Investors page at cardinalhealth.com.


About Cardinal Health
Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a $103 billion health care services company that improves the cost-effectiveness of health care. As the business behind health care, Cardinal Health helps pharmacies, hospitals, ambulatory surgery centers and physician offices focus on patient care while reducing costs, enhancing efficiency and improving quality. Cardinal Health is an essential link in the health care supply chain, providing pharmaceuticals and medical products to more than 60,000 locations each day. The company is also a leading manufacturer of medical and surgical products, including gloves, surgical apparel and fluid management products. In addition, the company supports the growing diagnostic industry by supplying medical products to clinical laboratories and operating the nation's largest network of radiopharmacies that dispense products to aid in the early diagnosis and treatment of disease. Ranked #19 on the Fortune 500, Cardinal Health employs more than 30,000 people worldwide. More information about the company may be found at cardinalhealth.com and @CardinalHealth on Twitter.

SOURCE: Cardinal Health

More Company News
04/13/2021

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...

04/07/2021

By Victor Crawford, Chief Executive Officer of the Pharmaceutical segment at Cardinal Health

04/07/2021

Cardinal Health (NYSE: CAH) Specialty Solutions today launched Cardinal Health™ Navista™ Tech Solutions (TS), an advanced suite of technology solutions to help community oncologists improve...

03/30/2021

Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2021 on May 6 prior to the opening of trading on the New York Stock Exchange. The company will...

View all company news »

* Required Fields